These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30389700)

  • 1. Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.
    Yanagi T; Watanabe M; Hata H; Kitamura S; Imafuku K; Yanagi H; Homma A; Wang L; Takahashi H; Shimizu H; Hatakeyama S
    Cancer Res; 2018 Dec; 78(24):6795-6806. PubMed ID: 30389700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of FAM83H promotes cell migration and invasion in cutaneous squamous cell carcinoma via impaired keratin distribution.
    Tokuchi K; Kitamura S; Maeda T; Watanabe M; Hatakeyama S; Kano S; Tanaka S; Ujiie H; Yanagi T
    J Dermatol Sci; 2021 Nov; 104(2):112-121. PubMed ID: 34657752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM29 mediates lung squamous cell carcinoma cell metastasis by regulating autophagic degradation of E-cadherin.
    Xu W; Chen B; Ke D; Chen X
    Aging (Albany NY); 2020 Jul; 12(13):13488-13501. PubMed ID: 32640423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM29 in Cutaneous Squamous Cell Carcinoma.
    Hsu CY; Yanagi T; Ujiie H
    Front Med (Lausanne); 2021; 8():804166. PubMed ID: 34988104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
    Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
    Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells.
    Xu W; Xu B; Yao Y; Yu X; Cao H; Zhang J; Liu J; Sheng H
    Oncol Rep; 2016 Sep; 36(3):1411-8. PubMed ID: 27430345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.
    Xu J; Li Z; Su Q; Zhao J; Ma J
    Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM29 as a novel biomarker in pancreatic adenocarcinoma.
    Sun H; Dai X; Han B
    Dis Markers; 2014; 2014():317817. PubMed ID: 24864129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARID1A Hypermethylation Disrupts Transcriptional Homeostasis to Promote Squamous Cell Carcinoma Progression.
    Luo Q; Wu X; Chang W; Zhao P; Zhu X; Chen H; Nan Y; Luo A; Zhou X; Su D; Jiao W; Liu Z
    Cancer Res; 2020 Feb; 80(3):406-417. PubMed ID: 32015157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer.
    Jiang T; Tang HM; Lu S; Yan DW; Yang YX; Peng ZH
    Med Oncol; 2013 Dec; 30(4):715. PubMed ID: 24078150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Catulin marks the invasion front of squamous cell carcinoma and is important for tumor cell metastasis.
    Cao C; Chen Y; Masood R; Sinha UK; Kobielak A
    Mol Cancer Res; 2012 Jul; 10(7):892-903. PubMed ID: 22648798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
    Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
    Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of the tight junction molecules claudin-1 and zonula occludens-1 mediates cell growth and invasion in oral squamous cell carcinoma.
    Babkair H; Yamazaki M; Uddin MS; Maruyama S; Abé T; Essa A; Sumita Y; Ahsan MS; Swelam W; Cheng J; Saku T
    Hum Pathol; 2016 Nov; 57():51-60. PubMed ID: 27436828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.
    Kanzaki A; Kudo M; Ansai S; Peng WX; Ishino K; Yamamoto T; Wada R; Fujii T; Teduka K; Kawahara K; Kawamoto Y; Kitamura T; Kawana S; Saeki H; Naito Z
    Int J Oncol; 2016 Mar; 48(3):1007-15. PubMed ID: 26782292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.